CTRI/2019/03/018224
Completed
未知
Association of Obesity and its pathophysiology with cognition in young age adults
Interactive Research School for Health Affairs IRSHA0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Interactive Research School for Health Affairs IRSHA
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Individuals of either sex in the age groups 18\-35 yrs
- •2\.Individuals with minimum education of 12th pass
- •3\.Individuals with average IQ as judged by normal learning abilities
Exclusion Criteria
- •1\. Individuals with sensory deficits
- •2\. Individuals with major neuropsychiatric disorders \& neurological disorders such as stroke \& brain haemorrhage
- •3\. Individuals with diabetes, hypertension and thyroid dysfunction
- •4\. Individuals with substance abuse disorders
- •5\. Pregnant and lactating females, females with PCOS
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
ASSOCIATION BETWEEN OBESITY PHENOTYPES, METABOLIC HEALTH AND NAFLDCTRI/2022/11/047422AIIMS New Delhi
Recruiting
Not Applicable
Prevalence of overweight and obesity and associated lifestyle, socio-demographic and environmental factors among children in the age of 4 - 13 years in the city of Zwolle.overgewicht en obesitasoverweight and obesity10024450NL-OMON33035VU-Windesheim4,600
Not yet recruiting
Not Applicable
Association of total body fat and belly fat in middle aged women of West IndiaCTRI/2024/04/065302Government Medical College Bhavnagar
Completed
Not Applicable
The impacts of obesity and abdominal obesity on gastrectomy in gastric cancer patientsKCT0004949The Catholic University of Korea, St. Vincent's Hospital305
Active, not recruiting
Phase 1
An investigation into the modulation of obesity associated monocyte/macrophage function, vascular inflammation and insulin resistance by PPAR agonist treatmentThe proposed study will investigate early indicators of cardiovascular disease and diabetes in healthy, obese men without a family history of diabetes and whether these are changed by treatment with the common PPAR agonists fenofibrate andpioglitazone.EUCTR2006-004296-35-GBThe Royal Group of Hospitals, Belfast Health and Social Care Trust80